Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Palvella Therapeutics, Inc. (PVLA) had Return on Equity of -27.85% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-17.43M |
|
-- |
|
-- |
|
$14.10M |
|
$-14.10M |
|
$-3.34M |
|
$-17.43M |
|
$-17.43M |
|
$-17.43M |
|
$-17.43M |
|
$-17.43M |
|
$-17.43M |
|
$-14.10M |
|
$-14.10M |
|
2.23M |
|
2.23M |
|
$-7.83 |
|
$-7.83 |
|
| Balance Sheet Financials | |
$88.23M |
|
-- |
|
-- |
|
$88.23M |
|
$12.04M |
|
-- |
|
$13.59M |
|
$25.63M |
|
$62.61M |
|
$62.61M |
|
$62.61M |
|
11.01M |
|
| Cash Flow Statement Financials | |
$-10.84M |
|
-- |
|
$87.09M |
|
$7.35M |
|
$83.60M |
|
$76.25M |
|
$0.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-27.85% |
-27.85% |
|
-19.76% |
|
-27.85% |
|
$5.69 |
|
$-4.87 |
|
$-4.87 |
|